LUTHERVILLE, Md., July 9, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today lauded the latest results achieved by the real-time, stop-sale system in Kentucky. Data released for the first six months of 2012 by the National Precursor Log Exchange (NPLEx) shows electronic technology in the Bluegrass State blocked the sale of more than 16,000 boxes of medicine containing pseudoephedrine (PSE) preventing more than 42,000 grams from potentially being diverted by meth criminals.
"The Commonwealth of Kentucky is ground zero in America's battle against methamphetamine production and abuse," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). "Thankfully, Kentucky is achieving success using real-time, stop-sale technology that allows retailers and law enforcement officials to block and track attempted purchases in real time. Data collected by the system is provided to police officers and allows them to build stronger cases and make more arrests. Earlier this year, the Kentucky General Assembly passed several anti-meth measures, including the implementation of a meth offender registry, which will make NPLEx even stronger. While meth production remains a significant challenge for the Commonwealth, NPLEx provides law enforcement with an opportunity to make real progress in the fight."
The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.
SOURCE National Association of Drug Diversion Investigators